SLI
1.986,02
PKT
+13,07
PKT
+0,66
%
Werbung
Analysen zu SLI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
21.04.05 | Novartis Underperform | Credit Suisse First Boston | |
19.04.05 | ABB (Asea Brown Boveri) Overweight | JP Morgan | |
19.04.05 | Roche Akkumulieren | Independent Research | |
19.04.05 | Novartis Buy | Merrill Lynch | |
19.04.05 | Roche Halten | Helaba Trust | |
19.04.05 | Roche Buy | Sarasin Research | |
18.04.05 | UBS Market Outperform | Vontobel | |
18.04.05 | Novartis Outperform | Goldman Sachs | |
19.04.05 | Roche Overweight | JP Morgan | |
18.04.05 | UBS Market Perform | Vontobel | |
19.04.05 | Novartis Neutral | JP Morgan | |
19.04.05 | Roche Equal weight | Lehman Brothers | |
18.04.05 | Nestlé Neutral | Sarasin Research | |
18.04.05 | Novartis Neutral | Sarasin Research | |
15.04.05 | Roche In-Line | Goldman Sachs | |
18.04.05 | Novartis Neutral | HypoVereinsbank | |
15.04.05 | Roche In-Line | Goldman Sachs | |
15.04.05 | Novartis Kaufen | Helaba Trust | |
18.04.05 | Roche Buy | Helvea | |
18.04.05 | Roche Buy | Sarasin Research | |
18.04.05 | Roche Outperform | HypoVereinsbank | |
14.04.05 | Novartis Reduce | UBS | |
14.04.05 | Novartis Reduce | UBS | |
14.04.05 | ABB (Asea Brown Boveri) Overweight | Lehman Brothers | |
15.04.05 | Roche Buy | SES Research | |
15.04.05 | Novartis Underperform | Credit Suisse First Boston | |
14.04.05 | Roche Halten | Helaba Trust | |
13.04.05 | Lonza Reduce | Sarasin Research | |
13.04.05 | Logitech Neutral | Sarasin Research | |
13.04.05 | Novartis Neutral | Sarasin Research | |
11.04.05 | Richemont Accumulate | Helvea | |
11.04.05 | Lonza Overweight | JP Morgan | |
11.04.05 | Givaudan Equal weight | Lehman Brothers | |
11.04.05 | Richemont Buy | Sarasin Research | |
11.04.05 | Zurich Insurance Neutral | JP Morgan | |
11.04.05 | Givaudan Underperform | HypoVereinsbank | |
11.04.05 | Swiss Life Akkumulieren | Nord LB | |
12.04.05 | Adecco SA Sell | Dresdner Kleinwort Wasserstein | |
11.04.05 | Givaudan Neutral | Helvea | |
11.04.05 | Adecco SA Accumulate | Helvea |